MedPath

Fetal Renal Artery Doppler in Patients With Preeclampsia

Recruiting
Conditions
Preeclampsia
Interventions
Other: fetal ultrasound
Registration Number
NCT06395974
Lead Sponsor
Assiut University
Brief Summary

Preeclampsia is a major devastating disorder affects 2:10% of pregnancies worldwide. preeclampsia may be associated with placental insufficiency which may cause fetal blood redistribution to essential organs like brain, heart, kidney.

Detailed Description

Preeclampsia is a major devastating medical condition that affects pregnant women after 20 weeks of pregnancy. It affects 2:10% of pregnancies worldwide according to World Health Organisation with higher incidence in developing countries.

Vascular endothelial dysfunction due to abnormal placentation is believed to be the main cause of multi-organ failure and uteroplacental insufficiency that occur in preeclampsia leading to major adverse effects in both mother and fetus.

Placental insufficiency causes a redistribution of fetal blood to essential organs ; brain, heart and adrenal glands by decreasing their vascular resistance on expense of peripheral organs such as kidney which exhibit increased vascular resistance and impaired perfusion. This is in contrast to normal pregnancies near term in which renal vascular resistance falls and increased blood flow to the kidneys is observed. Doppler ultrasound examination of vasculature of selected organs such as kidneys may have a role in detection of hemodynamic rearrangements that occur in cases of placental insufficiency and preeclampsia.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
88
Inclusion Criteria
  • a) Preeclampsia:

    • Women with preeclampsia >28 weeks of pregnancy.

    • Singleton pregnancy.

    • Women with intrauterine growth restriction and abnormal amniotic fluid volume to simulate real world data.

      b) Control:

    • Women with healthy pregnancy matched by closest gestational age.

Exclusion Criteria
  • ● Multiple pregnancy.

    • Known Congenital fetal malformations.
    • Women with other comorbidity such as ischemic heart disease, DM, Autoimmune disorders, kidney disease, neurological disorders, liver or haematological disorders.
    • Women unable to provide informed consent.
    • Women who refuse to participate

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
preeclampsiafetal ultrasound-
controlfetal ultrasound-
Primary Outcome Measures
NameTimeMethod
fetal renal artery doppler indices1 year

the difference between the Fetal renal artery Doppler indices between preeclamptic patients and women with healthy pregnancy

Middle cerberal artery doppler indices , Umbilical artery doppler indices and placental volume1 year
Secondary Outcome Measures
NameTimeMethod
neonatal outcome1 year

the ability of Fetal renal artery Doppler in prediction of neonatal complications.

Trial Locations

Locations (1)

Assiut university hospital

🇪🇬

Assiut, Egypt

© Copyright 2025. All Rights Reserved by MedPath